Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Graft Failure”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Large-scale testing (Phase 3)Study completedNCT03829488
What this trial is testing

Better Evidence for Selecting Transplant Fluids

Who this might be right for
End Stage Kidney DiseaseDelayed Graft FunctionKidney Transplant; Complications
The University of Queensland 808
Testing effectiveness (Phase 2)Ended earlyNCT00720629
What this trial is testing

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT00975975
What this trial is testing

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+8 more
Indiana University 17
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Not applicableUnknownNCT02922088
What this trial is testing

EU Multicenter Registry to Assess Outcomes in CABG Patients: Treatment of Vascular Conduits With DuraGraft [VASC]

Who this might be right for
Cardiovascular DiseasesCoronary Artery Disease
Somahlution LLC 2,964
Not applicableNot Yet RecruitingNCT07557862
What this trial is testing

Multi-Site STARgraft (10401) Trial

Who this might be right for
End Stage Renal Disease (ESRD)
Healionics Corporation 75
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Ended earlyNCT00086164
What this trial is testing

Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis

Who this might be right for
HyperplasiaChronic Renal Failure
Anesiva, Inc.
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Not applicableStudy completedNCT02790606
What this trial is testing

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)

Who this might be right for
StenosisRestenosis
C. R. Bard 110
Large-scale testing (Phase 3)Ended earlyNCT00447187
What this trial is testing

Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk

Who this might be right for
Corneal DiseasesCornea Transplant
Lux Biosciences, Inc. 368
Not applicableWithdrawnNCT04951934
What this trial is testing

Prospective Randomized International Study on the Reactivation of Burn Injuries

Who this might be right for
BurnsSkin Graft (Allograft)(Autograft) Failure
Emoled
Testing effectiveness (Phase 2)Study completedNCT01010217
What this trial is testing

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Who this might be right for
Blood Stem Cell Transplant FailureLeukemiaHematologic Malignancies
M.D. Anderson Cancer Center 176
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Large-scale testing (Phase 3)Study completedNCT00041925
What this trial is testing

Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures

Who this might be right for
Peripheral Vascular DiseasesArterial Occlusive DiseasesIschemia+2 more
Anesiva, Inc. 1,400
Testing effectiveness (Phase 2)Study completedNCT00003270
What this trial is testing

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Roswell Park Cancer Institute 20
Large-scale testing (Phase 3)Ended earlyNCT00447642
What this trial is testing

Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty

Who this might be right for
Corneal TransplantationCorneal Graft Rejection
Lux Biosciences, Inc. 122
Large-scale testing (Phase 3)Study completedNCT00042081
What this trial is testing

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

Who this might be right for
Coronary Artery Disease
Anesiva, Inc. 3,000
Early research (Phase 1)Study completedNCT00062621
What this trial is testing

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

Who this might be right for
Kidney Failure, ChronicMultiple Myeloma
National Institute of Allergy and Infectious Diseases (NIAID) 5
Not applicableActive Not RecruitingNCT05881278
What this trial is testing

XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)

Who this might be right for
Heart FailureTransplant; Failure, Heart
XVIVO Perfusion 141
Load More Results